NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations
Open Access
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 27 (1) , 21-35
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 245 references indexed in Scilit:
- The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defensesJournal of Experimental Medicine, 2012
- Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cellsJournal of Cell Biology, 2011
- Mature natural killer cells reset their responsiveness when exposed to an altered MHC environmentJournal of Experimental Medicine, 2010
- Pluripotent stem cell-derived natural killer cells for cancer therapyTranslational Research, 2010
- Monoclonal antibodies: versatile platforms for cancer immunotherapyNature Reviews Immunology, 2010
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- TGFβ in CancerCell, 2008
- Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β ReceptorJournal of Immunotherapy, 2008
- Evolutionary struggles between NK cells and virusesNature Reviews Immunology, 2008
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004